Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the slow growth of multiple fluid-filled cysts predominately in the kidney tubules and liver bile ducts. Elucidation of mechanisms that control cyst growth will provide the basis for rational therapeutic intervention. We used electrophysiological methods to identify lysophosphatidic acid (LPA) as a component of cyst fluid and serum that stimulates secretory Cl -transport in the epithelial cell type that lines renal cysts. LPA effects are manifested through receptors located on the basolateral membrane of the epithelial cells resulting in stimulation of channel activity in the apical membrane. Concentrations of LPA measured in human ADPKD cyst fluid and in normal serum are sufficient to maximally stimulate ion transport. Thus, cyst fluid seepage and/or leakage of vascular LPA into the interstitial space are capable of stimulating epithelial cell secretion resulting in cyst enlargement. These observations are particularly relevant to the rapid decline in renal function in late-stage disease and to the "third hit" hypothesis that renal injury exacerbates cyst growth.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic disease in humans with an estimated incidence of approximately 1 in 800 [1] . ADPKD is characterized by the growth of fluid filled cysts predominately in kidney tubules and liver bile ducts. The genes that are mutated in ADPKD encode proteins, polycystin 1 and 2 that are found in the primary cilia, cytoplasmic vesicles, endoplasmic reticulum and cell-cell and cell-extracellular matrix contacts. These proteins are either transient receptor potential Ca 2+ channels or proteins that regulate this class of Ca 2+ channels [1] [2] [3] . Disease-associated decreases in intracellular Ca 2+ modulate intracellular signaling pathways including those regulating cAMP levels and Cl -channel activity. Studies 1256 performed over a decade ago indicate that renal cyst expansion in PKD is driven by anion secretion [4] [5] [6] [7] [8] , and more recent studies have shown a similar profile in freshly isolated bile duct epithelia [9] . Inhibitor studies and electrophysiological analyses have shown that the cystic fibrosis transmembrane conductance regulator (CFTR) is one of the major Cl -channels responsible for secretion in both kidney and biliary cysts [7] [8] [9] .
While patients are born with numerous small cysts, cyst expansion and fibrosis in the surrounding tissue progresses slowly into middle age until the overall kidney size can be more than 10 fold normal. Despite the growing cysts, renal function is typically not compromised until the fifth decade but then the decline is precipitous usually requiring dialysis or transplantation within 5 years [10] . Interestingly, renal injury exacerbates cyst formation and expansion [11, 12] . An understanding of the mechanisms governing the acute changes in late stage ADPKD as well as factors contributed by renal injury is key to the development of treatment protocols to delay the complete loss of renal function.
A common occurrence during both injury and latestage disease is increased leakage of fluid from large surface cysts as well as an increase in vascular permeability [13] [14] [15] . Human cyst fluid has previously been shown to stimulate secretory activity in renal epithelial cells and to enhance cyst growth in vitro [16] [17] [18] . Both cyst fluid and vascular contents would be released into the interstitial space where they would have access to the basolateral side of the epithelial cells lining the cysts.
In the current studies, electrophysiological techniques were used to examine the effect of cyst fluid and fetal bovine serum (FBS) on the mpkCCD cl4 (mouse principal cells of the kidney cortical collecting duct, clone 4) cell line [19] , a model of the cell type that lines the majority of the cysts in ADPKD. We have identified the active component of the cyst fluid as lysophosphatidic acid (LPA), a compound present in the cyst fluid and serum in a concentration that maximally stimulates ion transport.
Materials and Methods
Human renal cyst fluid collection IRB approval for cyst fluid and tissue collection was secured prior to the initiation of this project. Cyst fluid was collected intra-operatively from patients undergoing either nephrectomies or cyst unroofing procedures. All human sample collections were obtained using de-identified containers in which only age and sex data were provided. Once samples were delivered to the laboratory, the fluid was flash-frozen in liquid nitrogen and stored at -80°C until analyzed for biological activity. mpkCCD cl4 cell culture mpkCCD cl4 cells were developed by Prof. Vandewalle and colleagues as a line expressing the characteristics of the principal cell type of the distal nephron and cortical collecting duct [19] . mpkCCD cl4 cells were grown in a humidified chamber at 37°C and 5% CO 2 . For electrophysiological measurements, the cells were seeded onto Transwell filters at 1/4 confluent density. The media was replaced thrice weekly and consisted of Dulbecco's modified Eagle's medium (DMEM): Ham's F12 basal media supplemented with 2% fetal bovine serum, 1 mM Glutamax, 25 U/mL penicillin, 25 mg/mL streptomycin, 12 mg/L ciprofloxacin, 5 mg/L transferrin, 20 µg/L sodium selenite, and 10 -7 M triiodothyronine.
Electrophysiology
Ussing-style electrophysiological measurements were used to measure net transepithelial transport as well as to monitor the transepithelial resistance as described previously [20] . Briefly, Transwell permeable membranes containing confluent (> 10 days post seeding) monolayers of mpkCCD cl4 cells were mounted in Ussing chambers, and connected to a DVC-1000 Voltage/Current Clamp (World Precision Instruments) with voltage and current electrodes on either side of the membrane. The cells were bathed in serum-free medium maintained at 37°C via water-jacketed buffer chambers on either side of the filter. Medium was circulated and kept at constant pH using a 5% CO 2 /95% O 2 gas lift. The spontaneous transepithelial potential difference was clamped to zero and the resulting SCC is a measure of net transepithelial ion transport. Non-zero voltage pulses were induced every 200 seconds and the current displacement during the pulse was used to calculate the transepithelial resistance via Ohm's law. Cultures with resistances lower than 1000 Ω • cm 2 were discarded. The time of addition of the stimulatory effector is defined as zero time.
Unless otherwise stated, each experiment was repeated 3-4 times. Because of variability in the magnitude of the stimulatory responses to cyst fluid from various patients, only one representative experiment is depicted.
LPA measurements
Levels of LPA molecular species were measured by extraction of cyst fluid followed by quantitation by tandem mass spectrometry on a Agilent 6410 Triple Quadrapole Mass Spectrometer. Cyst fluid (1 ml) with 125 ng 14:0 LPA internal standard was extracted in quadruplicate by vortexing with 4 ml MeOH:CHCl 3 (2:1) acidified with 0.2 ml 6 N HCl followed by cooling at -20°C for 30 min. The phases were split by the addition of 1 ml CHCl 3 and 1.25 ml H 2 O, vortexing, and centrifugation at 13,000xg for 20 min. The upper aqueous phase re-extracted with 2.5 ml CHCl 3 [21] . The pooled CHCl 3 phases were evaporated to dryness under N 2 and dissolved in 50 µl MeOH:CHCl 3 :300mM ammonium acetate (665:300:35), microfuged at 13,000xg to remove particulate matter. Extracted samples (8 µl) 
Results

Human Cyst Fluid and FBS Stimulate Transepithelial Ion Transport
The functional effects of cyst fluid were measured as changes in net transepithelial ion transport across high resistance epithelia formed by the mpkCCD cl4 cell line that displays the characteristics of the principal cell type of the distal nephron [19, 20] . Confluent cell monolayers grown on permeable supports were mounted in Ussing chambers and short circuit current (SCC) was used to measure electrogenic ion flux. By convention, a positive change in SCC is defined as anion moving in a secretory direction (serosal to luminal) or a cation moving in an absorptive direction (luminal to serosal).
The majority of the basal SCC is due to the flux of Na + in an absorptive direction [20] . This is inhibited by the addition of amiloride, a specific blocker of the epithelial sodium channel (ENaC). When renal cyst fluid from ADPKD patients was added to the basolateral bathing media (10% v/v), there were multiple changes in net ion movement ( Fig. 1 ). 30 min after the addition of the cyst LPA Stimulated Ion Transport M) was added to the apical bathing media 30 min. after the basolateral addition of cyst fluid to determine what proportion of the remaining SCC is due to sodium reabsorption via ENaC. This figure is representative of over 50 experiments performed with cyst fluid from 10 different patients. B: Sidedness of cyst fluid stimulation of ion transport in the mpkCCD cl4 cell line. mpkCCD cl4 cells were grown to confluence on permeable Transwell supports and net ion transport was measured as short circuit current (SCC). At time t = -10 min., cyst fluid was added to the apical bathing media to obtain a final concentration of 10%. 10 min. later, cyst fluid was added to the serosal bathing media to obtain a final concentration of 10%. In both cases, an equal volume of fluid was added to the contralateral side to balance the addition of the cyst fluid. C: At time t = 0 min., cyst fluid that had been boiled for 10 min. was added to the apical bathing media to obtain a final concentration of 10%. An equal volume of incubation medium was added to the contralateral side to balance the addition of the cyst fluid.
fluid, amiloride was added to the apical bathing media and this decreased the remaining ion transport to zero.
In all studies, the cyst fluid stimulated an immediate biphasic increase in SCC. In cultures with high starting currents (> 2 µA/cm 2 ) this was followed by a sustained drop below the basal level. In cultures with lower basal currents this drop in baseline transport was not observed (e.g., Fig. 2C ). The addition of cyst fluid has been repeated using samples from 13 ADPKD patients in numerous independent experiments in cultures grown months apart. 10 of the 13 cyst fluids produced similar changes in ion transport in mpkCCD cl4 cells, albeit with different magnitudes. In the following experiments, cyst fluids from several patients were used because there was insufficient fluid from a single patient to perform all experiments.
To determine if the active component of the cyst fluid required a receptor or other membrane-specific component, the cyst fluid was added first to the apical media and after 10 min to the serosal media (Fig. 1B) . Apical addition failed to elicit the characteristic response. Basolateral addition to the same culture caused the typical Blazer-Yost/Blacklock/Flaig/Bacallao/Gattone M) was added to the apical bathing media of one of two cultures grown and analyzed in parallel. 10 min. after addition of amiloride, renal cyst fluid from the same patient (10% final volume) was added to the serosal bathing media of both cultures. Simultaneously, an equal volume of media was added to apical side to equalize the volumes. B: Three cultures of mpkCCD cl4 cells were grown in parallel on the same Transwell plate and analyzed in tandem. After a stabilization period, amiloride (10 -5 M) was added to the apical bathing media of one of the three cultures (t = -10 min.). At time zero, forskolin was added to one of the cultures that was not pretreated and to the one that was pre-treated with amiloride. The remaining culture received diluents only and served as a control. 30 min. after the addition of forskolin, amiloride (10 -5 M) was added to all cultures. C: Effect of CFTR chloride channel inhibitor pretreatment on cyst fluid stimulation of ion transport in the mpkCCD cl4 cell line. Two cultures of mpkCCD cl4 cells were grown in parallel on the same Transwell plate and analyzed in tandem. GlyH-101 was added at time -10 min. with the control receiving diluent only. At time t = 0, identical aliquots (10% final volume) of the same cyst fluid were added to the serosal side of both tissues. Simultaneously, an equal volume of media was added to apical side to equalize the volumes.
response seen in Fig. 1A . These results indicate that the stimulatory response is associated with the basolateral membrane.
A sample of cyst fluid that was boiled for 10 min. to denature the fluid protein components caused the same response in the renal cells as the non-denatured fluid (Fig.  1C) . Thus, in agreement with previous findings [17] , these results suggest that the active component is not a protein.
Cyst Fluid Stimulates Chloride Secretion But Not Sodium Absorption
Since the majority of the basal SCC is due to ENaCmediated Na + flux, amiloride addition caused an immediate decrease in the basal current ( Fig. 2A) . Addition of cyst fluid from the same patient to control and amiloride pretreated cells resulted in a similar pattern of changes in ion flux (Fig. 2A) . These results indicate that ENaCmediated Na + transport is not involved in the response to cyst fluid stimulation.
Previous studies conducted using the MDCK cell line and primary cultures of ADPKD renal epithelia found that the stimulatory activity in human cyst fluid is a lipidlike molecule identified as an endogenous mammalian forskolin [17, 18] . However within the context of a different renal cell model and a different assay technique, we did not find that forskolin stimulated a response similar to that obtained with cyst fluid (Fig. 2B ). Forskolin caused a slow, sustained increase in transport. Pre-treatment with amiloride inhibited a subsequent response to forskolin. These results indicate that the forskolin-stimulated ion transport is predominately due to transepithelial Na + transport via ENaC.
GlyH-101 is a specific inhibitor of CFTR [22, 23] . Pretreatment with GlyH-101 substantially inhibited the cyst-fluid-stimulated ion transport response (Fig. 2C) . GlyH-101 caused an addition effect when added but this returned to baseline before the addition of the cyst fluid.
It is likely that other transporters are also either directly or secondarily involved in the stimulatory response. For example, increases in intracellular Ca on the serosal side inhibited stimulated Cl -secretion by about 50% while pretreatment on the apical face was without effect (data not shown). The identity and role of the alternate channels involved in the response are beyond the scope of this work which is predominately directed to identifying the active components in the cyst fluid responsible for the major Cl -secretory event.
Lysophosphatic Acid (LPA) is the Active Component in the ADPKD Cyst Fluid
Several bioactive lipids stimulate or inhibit ion transport in high resistance epithelia. The majority of these are prostaglandins formed by the action of cyclooxygenase. Pre-treatment with indomethacin, a cyclooxygenase inhibitor, did not alter the cyst fluid stimulation of ion transport (Fig. 3A) .
Two other bioactive lipid mediators are LPA and sphingosine-1-phosphate (S-1-P). The ion transport LPA Stimulated Ion Transport Blazer-Yost/Blacklock/Flaig/Bacallao/Gattone response to LPA was identical to the response to renal cyst fluid. Responses to S-1-P were consistently minimal compared to those elicited by LPA (Fig. 3B) and may represent S-1-P cross-over binding to an LPA receptor.
A limited dose response for LPA indicated that concentrations from 0.05 to 50 µM stimulated a maximal response in mpkCCD cl4 cells. In Fig. 3C , responses to concentrations from 0.01 to 1 µM LPA are compared to 10% cyst fluid. 5 and 50 µM were also used and the responses to these high concentrations were also not different than the cyst fluid (data not shown).
Multiple reaction monitoring by tandem mass spectrometry was used to quantitate the concentration of LPA molecular species in the cyst fluid collected from one patient. The cyst fluid contained 4.0 ± 0.4 µM 16:0 LPA and 1.4 ± 0.04 µM 18:1 LPA. 18:0 LPA was present at levels too low to accurately quantify with our methods. The combined concentrations of the various species are above 5 µM and, therefore, based on the dose response relationship, addition of cyst fluid at a 10% volume/volume dilution (final LPA concentration above 0.5 µM) would stimulate a maximal response. 5 . Stimulation of ion transport using fetal bovine serum. 10% (vol/vol) FBS was added to the serosal bathing media at time t = 0. Simultaneously, an equal volume of media was added to apical side to equalize the volumes. Amiloride (10 -5 M) was added to the apical bathing media 30 min. After the basolateral addition of FBS to determine the proportion of the remaining SCC that is due to sodium reabsorption via ENaC. Fig. 6 . Stimulation of ion transport using size fractionated cyst fluid. Cyst fluid was fractionated using Centriprep centrifuge filters with a 100 kDa cutoff. The filtrate was added to one of two mpkCCD cl 4 cultures to obtain a final concentration of a 10%. The retentate was returned to the original cyst volume and was subsequently added at a final concentration of 10%. 30 min. after the addition of the cyst fluid fractions, amiloride (10 -5 M) was added to the apical bathing solution.
LPA Stimulated Ion Transport
Cyst Fluid Stimulated Transport is Receptor Mediated LPA responses are mediated via a family of receptors found on the basolateral membranes of epithelial cells [24, 25] . L-NASPA (N-palmitoyl-L-serine phosphoric acid) has been described as a general LPA receptor antagonist with some agonist properties or, alternatively, as an LPA mimetic [26, 27] . When NASPA is added to the basolateral bathing media, there is an immediate response that mimicked the response to LPA or 10 % cyst fluid (Fig. 4A) . L-NASPA pre-treatment completely inhibits a subsequent response to cyst fluid (n = 4). These data suggest that the stimulatory effect is mediated via an LPA receptor.
There are 5 characterized LPA receptors named LPA1-5 [25] . Two structurally distinct compounds, Ki16425 and VPC51299, are dual LPA1/LPA3 antagonists [28, 29] . Neither of these agents inhibited LPA-stimulated transport in the renal cells (Fig. 4B) . Likewise, DDP (dodecylphosphate) an LPA2 agonist/ LPA3 antagonist [30] had no effect on cyst fluid stimulated transport (Fig. 4C) . Unlike receptors LPA1-3, LPA5 preferentially binds ether LPA [25] . When equimolar concentrations of ether and ester l inked LPA were compared, ester linked LPA was more potent (Fig. 4D) suggesting that the LPA5 is not involved in ion transport in the renal cells. By process of elimination, the most likely receptor is LPA4. Unfortunately no specific agonists or antagonists of the LPA4 receptor have been described. However, this receptor does regulate cAMP levels and is, therefore, a likely candidate responsible for changes in Cl -channel activity.
Fetal Bovine Serum stimulates a Similar Cl -
Secretory Response
LPA is also present in serum, particularly during inflammatory responses. Therefore we tested the ability of fetal bovine serum (FBS) to stimulate a similar secretory response. The addition of a 10% (v/v) concentration of FBS elicited a response in the renal cells that was virtually identical to the response caused by cyst fluid (Fig. 5) .
LPA is Bound to a High Molecular Weight Component in Cyst Fluid and Serum
High levels of free LPA in cyst fluid would be expected to diffuse across the epithelial barrier and interact with receptors on the basolateral membrane. However, under normal conditions there is no evidence of such on-going stimulation. One possible explanation is that the LPA is bound to proteins that are abundant in the cyst fluid [31] and, therefore, retained inside the cyst lumen. Untreated cyst fluid was separated into fractions greater and less than 100 kDa using Centri-prep centrifuge filters. The filtrate containing components less than 100 kDa had very little stimulatory activity while the fraction with components approximately 100 kDa and higher showed a stimulatory activity that was virtually identical to the unfractionated cyst fluid (Fig. 6) .
Discussion
In a cell line with characteristics of the principal cell type, cyst fluid from ADPKD patients stimulates Cl -secretory activity via CFTR. CFTR involvement in cyst expansion is well documented and forms the basis of therapeutic intervention designed to curtail cyst growth [32, 33] . The transient nature of the Cl -secretory responses in these studies is a reflection of the method of transepithelial voltage clamp with identical solutions on both sides of the epithelium. This provides a determination of the channels that are activated while the duration of the ion flux in vivo will be dependent on the composition of the fluid on either side of the cells as well as the activity of basolateral channels and pumps. In addition, it is important to note that cyst growth is very slow thus even transient secretory events are sufficient, over time, to cause cyst growth.
In 1992, Grantham and colleagues demonstrated that human cyst fluid or serum from ADPKD patients stimulated fluid secretion in cultures of MDCK cells and in primary cultures of human PKD kidney cells [4] [5] [6] 16] . These investigators identified the active component as a forskolin-like molecule [18] . Analogous to the previous studies, we found that both cyst fluid and serum can stimulate the same response. We have also found that the active component in cyst fluid is a lipid. However, in the mpkCCD cl4 cell line, forskolin stimulates an ENaC-mediated Na + flux while cyst fluid causes activation of Cl -secretory channels. We have identified LPA as the most likely stimulatory component of cyst fluid. This conclusion is based on the multiphasic characteristics of the stimulatory responses to cyst fluid and LPA as well as the action of a general LPA receptor antagonist/mimetic. Using specific receptor antagonists, the response to LPA/cyst fluid does not appear to be mediated by receptors LPA1-3 or LPA5.
By process of elimination, this suggests either LPA4 or an uncharacterized receptor. Unfortunately, there are no specific receptor modulators for LPA4 but, interestingly, this receptor has the ability to mobilize Ca 2+ and it is the only LPA receptor where ligand binding increases cAMP [34, 35] .
Human [16] or bovine (this study) serum challenge mimics the response to cyst fluid. Human serum LPA levels vary according to gender and health of the individual, however, circulating levels in healthy individuals are in the low micromolar range [36] . We have found a maximal response to LPA concentrations at and above 0.05 µM indicating that serum contains sufficient LPA to maximally activate Cl -channels. Likewise the cyst fluid contains sufficient LPA to maximally stimulate ion flux.
Given the relatively high concentrations of LPA in biological fluid, why does this bioactive lipid not modulate normal renal function? The answer to this question is likely in its well documented binding to serum proteins. Lysophospholipids including LPA bind serum proteins such as albumin and gelsolin [37] [38] [39] . Both rodent and human cyst fluid contain a remarkably high abundance of proteins including albumin and gelsolin [31, 40] . After a molecular weight separation, the LPA activity tracks with large (> 100 kDa) molecular complexes. While bound lysophosphatidates are able to cause cellular responses [37] , the protein-lipid complexes are large enough to assure that the bioactive lipid cannot diffuse across endothelial or epithelial cells under normal conditions and, therefore, is not normally available for receptor binding on the basolateral side of the cells lining the cyst.
ADPKD is characterized clinically by a slowly progressive disease where end-stage renal disease typically occurs in the middle of the fifth decade of life [10] . Cysts grow slowly during ageing with surprisingly little effect on renal function. However when a critical point is reached, renal function declines rapidly [10] . The rapidity of the functional changes suggests precipitating causes that may be influenced by tissue damage during ageing. Renal injury also exacerbates cystic development and growth independently of the type of injury [11, 12] . It has been suggested that subclinical kidney injury may play a role in the heterogeneity seen during cyst growth in humans [11] .
The majority of the renal tissue in a young person with ADPKD is normal. Only a small number of cells expressing the mutated gene form cysts giving rise to the hypothesis of a "second hit" usually envisaged Cell Physiol Biochem 2011; 28:1255 -1264 
